Product: A solution for managing fecal incontinence in patients
Industry: Medicine
Location: Delhi
Bringing a solution for a market of 3-4 million patients in India in general wards and ICUs suffering from fecal incontinence, ConSure expects to touch lives of millions of people worldwide. While the product has still not been released commercially as it is undergoing clinical trails and awaiting ethical clearance from the government, ConSure expects a turnover of $30-40 mn in next 3 years, with the team expanding to 25-30 from three people at present. Having a network of people from IIT, AIIMS, and practising senior doctors, Nishith Chasmawala, the co-founder, says his firm is two years ahead of any Indian company that may be its competitor in future. ConSure has filed for 5 patents internationally, and is looking for partners and distributors to tap the $7 bn global market that exists for them.
| Founder: Nishith Chasmawala |
| Co-founder: Amit Sharma, Sandeep Singh |
| Investors: $150,000 in funding from Department of Biotechnology |
| Mentors: Paul Yock, Balam Bhargava, Rajeev Doshi |
| Key Clients/Customers: N/A |
| Top-Line: N/A |
| URL: N/A |
Â
 |
| Nishith Chasmawala, Sandeep Singh and Amit Sharma |
| < Prev | Next > |
|---|
